Anti-ROR1 Antibody (Zilovertamab)
Catalog No.
F2111
Anti-ROR1 Antibody (Zilovertamab)
Featured Products
Zilovertamab is a humanized monoclonal antibody that is primarily used to treat B-cell malignancies. It works by targeting ROR1 (receptor tyrosine kinase-like orphan receptor 1), blocking its signaling pathway, thereby inhibiting the growth and survival of tumor cells. Zilovertamab consists of an IgG1 subtype antibody structure that can specifically bind to and neutralize ROR1, thereby interfering with the proliferation and migration of tumor cells.
146.14 kDa
Dry ice
2485779-13-1
-80°C
2 years
Liquid
1 mg/mL
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
UC-961, Cirmtuzumab
100 mM Pro 20 mM Arg pH 5.0.
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
ROR1
Please avoid freeze-thaw cycles.